Summaries for patients. Palifermin can prevent severe oral mucositis during chemotherapy.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000903:Antibiotics, Antineoplastic / Q000009:adverse effects; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D004317:Doxorubicin / Q000009:adverse effects; D005260:Female; D051523:Fibroblast Growth Factor 7 / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D008297:Male; D008875:Middle Aged; D009061:Mouth Mucosa / Q000187:drug effects / Q000473:pathology; D012509:Sarcoma / Q000188:drug therapy*; D013280:Stomatitis / Q000188:drug therapy / Q000517:prevention & control*; D055815:Young Adult
D000903:Antibiotics, Antineoplastic; D051523:Fibroblast Growth Factor 7; D004317:Doxorubicin